Start the conversation
3/16/15: Shares of Valeant Pharmaceuticals International Inc. (NYSE: VRX) gained 2.49% this afternoon on news it raised its buyout offer for Salix Pharmaceuticals Ltd. (Nasdaq: SLXP) to $10.96 billion. Salix accepted the $173-per-share offer, effectively knocking Valeant rival Endo International Plc. (Nasdaq: ENDP) out of the bidding process. Shares of Salix were up nearly 2% on the day.